Single-cell RNA sequencing in dissecting microenvironment of age-related macular degeneration: Challenges and perspectives.

Age-related macular degeneration Microenvironment Retina Single-cell RNA sequencing Transcriptome

Journal

Ageing research reviews
ISSN: 1872-9649
Titre abrégé: Ageing Res Rev
Pays: England
ID NLM: 101128963

Informations de publication

Date de publication:
09 2023
Historique:
received: 16 09 2022
revised: 29 04 2023
accepted: 04 08 2023
medline: 7 9 2023
pubmed: 8 8 2023
entrez: 7 8 2023
Statut: ppublish

Résumé

Age-related macular degeneration (AMD) is the leading cause of blindness in individuals over the age of 50 years, yet its etiology and pathogenesis largely remain uncovered. Single-cell RNA sequencing (scRNA-seq) technologies are recently developed and have a number of advantages over conventional bulk RNA sequencing techniques in uncovering the heterogeneity of complex microenvironments containing numerous cell types and cell communications during various biological processes. In this review, we summarize the latest discovered cellular components and regulatory mechanisms during AMD development revealed by scRNA-seq. In addition, we discuss the main challenges and future directions in exploring the pathophysiology of AMD equipped with single-cell technologies. Our review underscores the importance of multimodal single-cell platforms (such as single-cell spatiotemporal multi-omics and single-cell exosome omics) as new approaches for basic and clinical AMD research in identifying biomarker, characterizing cellular responses to drug treatment and environmental stimulation.

Identifiants

pubmed: 37549871
pii: S1568-1637(23)00189-7
doi: 10.1016/j.arr.2023.102030
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

102030

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Bo Qin reports financial support was provided by Natural Science Foundation of Guangdong Province, China. Bo Qin reports financial support was provided by Hunan Provincial Natural Science Foundation of China. Bo Qin reports financial support was provided by Shenzhen Science and Technology Innovation Committee, China. Bo Qin reports financial support was provided by Scientific research program of Xiangjiang Philanthropy Foundation. Bo Qin reports financial support was provided by Science Research Grant of Aier Eye Hospital Group. Dongcheng Liu reports financial support was provided by Shenzhen Science and Technology Innovation Committee, China. Dongcheng Liu reports financial support was provided by Science Research Grant of Aier Eye Hospital Group.

Auteurs

Yao Tan (Y)

Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China.

Jianguo Huang (J)

Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China.

Deshuang Li (D)

Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China.

Chang Zou (C)

Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China; Shenzhen Aier Ophthalmic Technology Institute, Shenzhen, China; School of Life and Health Sciences, The Chinese University of Kong Hong, Shenzhen 518000, Guangdong, China. Electronic address: zouchang@cuhk.edu.cn.

Dongcheng Liu (D)

Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China; Shenzhen Aier Ophthalmic Technology Institute, Shenzhen, China. Electronic address: ldc2025@163.com.

Bo Qin (B)

Shenzhen Aier Eye Hospital, Aier Eye Hospital, Jinan University, Shenzhen, China; Shenzhen Aier Ophthalmic Technology Institute, Shenzhen, China; Aier School of Ophthalmology, Central South University, Changsha, China. Electronic address: qinbozf@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH